All News

Mary Lisbeth D'Amico's fortnightly funding column looks at the contenders for Europe’s premier exchange for growth stocks.

A spin-out from the University of Surrey, England, is developing a new process to make silicon emit light – potentially cutting the cost of optical components.

“If A is success in life, then A equals x plus y plus z. Work is x; y is play; and z is keeping your mouth shut.” Albert Einstein

Despite the naysayers, more and more women are gaining success in the business of science. Our global investigation shows what it takes: good education, determination, a good employer, and some luck. Memo to government – Help them out.

Research-intensive companies outperform the FTSE average Source: UK Dept. of Trade & Industry

Chewing gum, underwater robots and other technologies, at a UK investor showcase

If you want to lead innovation in R&D, don’t neglect the crucial human factor, says Georges Haour from the IMD in Lausanne, Switzerland.

Steelmaker Arcelor, carmaker Daimler-Benz and some 50 companies are joining an effort by the French National Center for Scientific Research to form an education and research network to scout new metallic materials for industrial use.

Sigma-Aldrich, a US-based Nasdaq-listed life science company, has agreed to license a gene delivery technology from Oxford BioMedica and will pay $5 million for a stake in the spin out from Oxford University.

Imperial College London's technology commercialisation company is betting on a spin-out company, deltaDOT, to speed detection and decrease costs of finding new proteins for drug discovery.

A new life-science fund said it raised €240.3 million – and promptly announced its first two investments.